Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s diseaseMathias Jucker, Bernardino Ghetti, John M. Ringman et al.|Nature Medicine|2019Cited by 948
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s diseaseStephen Salloway, Paul Aisen, Martin R. Farlow et al.|Nature Medicine|2021Cited by 365
Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer diseaseEric McDade, Robert A. Koeppe, Guoqiao Wang et al.|Neurology|2018Cited by 322
The DIAN‐TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression modelRandall J. Bateman, Chengjie Xiong, Tammie L.S. Benzinger et al.|Alzheimer s & Dementia|2016Cited by 303
A novel cognitive disease progression model for clinical trials in autosomal‐dominant Alzheimer's diseaseGuoqiao Wang, Scott Berry, Chengjie Xiong et al.|Statistics in Medicine|2018Cited by 65